Emily M. Garabedian, Ph.D. - Publications
Affiliations: | 2000 | Washington University, Saint Louis, St. Louis, MO |
Area:
Cell Biology, Genetics, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2002 | Hu Y, Ippolito JE, Garabedian EM, Humphrey PA, Gordon JI. Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice. The Journal of Biological Chemistry. 277: 44462-74. PMID 12228243 DOI: 10.1074/Jbc.M205784200 | 0.442 | |||
2002 | Song SK, Qu Z, Garabedian EM, Gordon JI, Milbrandt J, Ackerman JJ. Improved magnetic resonance imaging detection of prostate cancer in a transgenic mouse model. Cancer Research. 62: 1555-8. PMID 11888935 | 0.53 | |||
2001 | Abdulkadir SA, Qu Z, Garabedian E, Song SK, Peters TJ, Svaren J, Carbone JM, Naughton CK, Catalona WJ, Ackerman JJ, Gordon JI, Humphrey PA, Milbrandt J. Impaired prostate tumorigenesis in Egr1-deficient mice. Nature Medicine. 7: 101-7. PMID 11135623 DOI: 10.1038/83231 | 0.59 | |||
1998 | Garabedian EM, Humphrey PA, Gordon JI. A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells. Proceedings of the National Academy of Sciences of the United States of America. 95: 15382-7. PMID 9860977 DOI: 10.1073/Pnas.95.26.15382 | 0.633 | |||
1997 | Garabedian EM, Roberts LJ, McNevin MS, Gordon JI. Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice. The Journal of Biological Chemistry. 272: 23729-40. PMID 9295317 DOI: 10.1074/Jbc.272.38.23729 | 0.476 | |||
Show low-probability matches. |